Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Brazil / NCT07317232
Recruiting Not applicable

Ayahuasca, Esketamine and Premenstrual Symptoms

NCT07317232 · tracked via the Priya Life Science Brazil tracker
Sponsor
University of Sao Paulo
Phase
Not applicable
Started
2025-12-20
Last updated
2026-01-05

Condition(s) studied

Healthy Women Volunteers

Investigational drug(s) / intervention(s)

Ayahuasca →Esketamine →

Ayahuasca: oral ayahuasca

Esketamine: oral esketamine

Study summary

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine on premenstrual symptoms.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * healthy volunteers Exclusion Criteria: * psychiatric and other medical comorbidities

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital das Clínicas da FMRP-USP Ribeirão Preto Brazil Recruiting

More University of Sao Paulo trials in Brazil

Performance of Next-X in Alveolar Ridge Preservation Recruiting
SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE Active, not recruiting
Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. Recruiting
Effects of Periodontitis on Heart Rate Variability Active, not recruiting
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias Active, not recruiting

Other trials for the same condition

Ayahuasca, Esketamine and Body Image Perception Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07317232 on ClinicalTrials.gov ↗ ← All trials in Brazil